ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2449

Cognitive Functioning Among Individuals with Systemic Lupus Erythematosus: A Population-Based Study

Laura Plantinga1, C. Barrett Bowling2, Charmayne Dunlop-Thomas1, Courtney Hoge1, Bradley Pearce1, Cristina Drenkard1 and S. Sam Lim1, 1Emory University, Atlanta, GA, 2Duke University, Durham, NC

Meeting: ACR Convergence 2023

Keywords: Cognitive dysfunction, Epidemiology, Measurement, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: Abstracts: Epidemiology & Public Health II

Session Type: Abstract Session

Session Time: 2:00PM-3:30PM

Background/Purpose: Studies of objectively measured cognitive dysfunction in SLE are often limited by small sample size, limited generalizability, and lack of diversity. We sought to comprehensively describe cognitive functioning and its correlates among participants recruited from a population-based, primarily Black U.S. cohort.

Methods: Participants (n=200; mean age, 42.6; 87.5% female, 86.5% Black, 5.0% Hispanic) completed in-person study visits (10/2019-5/2022), which included: (1) the NIH Toolbox Fluid Cognition Battery (episodic memory, working memory, attention and inhibitory control, cognitive flexibility, processing speed, overall composite measure; expressed as T-scores, adjusted for age, gender, race/ethnicity, and education); and (2) two brief screening tests, (a) a clock-drawing task (score range, 0-15; higher score=better performance) and (b) the Trail Making Test (TMT) B task (time in seconds, faster time=better performance). An additional 236 participants completed virtual study visits (10/2020-11/2021), which included NIH Toolbox episodic and working memory modules only. Descriptive statistics were calculated for all measures and the adjusted associations of various participant characteristics with the overall fluid cognition score were assessed with multivariable linear regression. Scatterplots and pairwise correlations were used to estimate relationships between cognitive functioning measures.

Results: The mean adjusted overall fluid cognition T-score was 45.3, ~0.5 SD below the general population mean; 31% participants scored < 40 ( >1 SD below the mean), suggesting impairment. The mean score for attention and inhibitory control was nearly 1 SD below average (Figure 1). Adjusted fluid cognition T-scores were not associated with age, race, ethnicity, or gender, but those who had a high school education or less vs. having a college degree or higher had 5.3 points ( >0.5 SD) lower score. Current working status was associated with a 7.2-point higher adjusted T-score, while higher depression, SLE activity, and SLE damage scores were associated with slightly lower T-scores (not statistically significant; Figure 2). Clock score (median=14, interquartile range, 13-15) was weakly correlated with fluid cognition T-score (r=0.17, P=0.01), while TMT B time (median=90.3, interquartile range, 71.9-121.1 s) was moderately correlated with fluid cognition T-score (Figure 3). Moreover, 2.5% of individuals did not complete the TMT B within 300 s, suggesting impairment.

Conclusion: Our results suggest individuals with SLE commonly suffer from deficits in fluid cognition, particularly attention and inhibitory control. Higher educational attainment and working status may be protective against impairment, but reverse causality may contribute to this observed pattern. Additionally, we found that multi-domain measurement of global fluid cognition among these individuals may provide nuanced information beyond that available from screening tasks that are designed primarily to detect impairment among older adults. Together, these results inform potential interventions to support cognitive function among individuals with SLE.

Supporting image 1

Figure 1. Mean fully adjusted* NIH Toolbox Fluid Cognition Battery T-scores among individuals with SLE, by visit type.

Supporting image 2

Figure 2. Adjusted differences in fluid cognition T-score by individual characteristics. HS, high school; BMI, body mass index; SLAQ, SLE Activity Questionnaire; BILD, Brief Index of Lupus Damage.

Supporting image 3

Figure 3. Scatterplot of Trail Making Test B time vs. fully adjusted fluid cognition T-Score. Line, fitted values; shaded area, 95% CI.


Disclosures: L. Plantinga: None; C. Bowling: None; C. Dunlop-Thomas: None; C. Hoge: None; B. Pearce: None; C. Drenkard: None; S. Lim: None.

To cite this abstract in AMA style:

Plantinga L, Bowling C, Dunlop-Thomas C, Hoge C, Pearce B, Drenkard C, Lim S. Cognitive Functioning Among Individuals with Systemic Lupus Erythematosus: A Population-Based Study [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/cognitive-functioning-among-individuals-with-systemic-lupus-erythematosus-a-population-based-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cognitive-functioning-among-individuals-with-systemic-lupus-erythematosus-a-population-based-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology